Monoclonal antibody shows promise in slowing progression of ALS

New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.

Medtronic, Allurion Launches AI-Powered Weight Loss Pilot

What You Should Know: Allurion, a company dedicated to ending obesity launches a pilot collaboration agreement with Medtronic to expand access to Allurion’s AI-powered weight

June 22, 2023

Edwards, Medtronic post low-risk TAVR data, allaying fears of market disruption

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Edwards Lifesciences and Medtronic reported

October 25, 2023

AbbVie fully ditches I-Mab’s CD47 drug after initial 2022 pullback from $1B+ bet

AbbVie will end the last parts of its CD47 agreement with I-Mab, the Maryland and Shanghai biotech disclosed in a Friday SEC filing. The Chicago-area

September 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.